New crown pneumonia Zhong Nanshan: China’s first vaccines to be announced soon

Chinese Academy of Engineering academician Zhong Nanshan on Tuesday (22) in the first hospital of Guangzhou Medical University in Guangdong, attended the opening ceremony of the National Center for Respiratory Medicine, introduced the progress of the prevention and control of the new crown epidemic, and said China’s first batch of vaccines will soon be announced.

    Zhong Nanshan revealed that the first, the second soon vaccine will be launched, the Chinese people can soon be inoculated, and stressed that in addition to strict prevention and control, but also vaccination, two roads to solve the problem.

    Zhong Nanshan also said that the domestic epidemic prevention and control is good, but always tighten the string, the construction of the National Center for Respiratory Medicine, he believes that in addition to continue to work in the “medical education, research, prevention and management” five areas, but also to increase the “production” to promote the development of related industries, and to strengthen the early prevention and early diagnosis and treatment of common diseases. He continued that Guangzhou dared to hold a marathon of more than 20,000 people, showing the confidence of the leaders and people of Guangdong and Guangzhou in fighting the epidemic, “If next year’s Spring Festival is very orderly and can travel, it will be a great success”.

    On the other hand, Wu Zunyou, chief epidemiologist of the Chinese CDC, recently told the internal media that although he was not sure of the protective effect produced by the new crown vaccine, it was still the most important technical measure for humans to control the epidemic. In terms of antibodies, he said that with reference to other coronaviruses, the effective protection period of antibodies after natural infection is generally 6 to 12 months, and some people may not be able to detect antibodies after 3 months, because there are differences between individuals, and the high and low antibodies and the long and short duration are related to the patient’s age, symptoms, and the amount of virus, etc.